What is Altimmune's tax on share settlement?

Altimmune (ALT) reported tax on share settlement of $695K in Q1 2026.

How has Altimmune's tax on share settlement changed year-over-year?

Altimmune's tax on share settlement increased by 2.5% year-over-year, from $678K to $695K.

What is the long-term trend for Altimmune's tax on share settlement?

Over 2 years (2023 to 2025), Altimmune's tax on share settlement has grown at a 14.7% compound annual growth rate (CAGR), from $539K to $709K.

What does tax on share settlement mean?

Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.

Altimmune ALT Tax on Share Settlement

Tax on Share Settlement at other companies

Viking TherapeuticsVKTX

$0—

MeiraGTx Holdings plcMGTX

$5.96M+116%

BioCryst PharmaceuticalsBCRX

$1.19M-12.1%

Corcept TherapeuticsCORT

$5.76M-63.6%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's tax on share settlement?: Altimmune (ALT) reported tax on share settlement of $695K in Q1 2026.
How has Altimmune's tax on share settlement changed year-over-year?: Altimmune's tax on share settlement increased by 2.5% year-over-year, from $678K to $695K.
What is the long-term trend for Altimmune's tax on share settlement?: Over 2 years (2023 to 2025), Altimmune's tax on share settlement has grown at a 14.7% compound annual growth rate (CAGR), from $539K to $709K.
What does tax on share settlement mean?: Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.